<i>CBRS expects deal with Dr. Pepper to pay off in 2000</i>
(September 2 – 16:20 ET) – CBRS is reiterating its A1 rating on Cadbury Schweppes PLC’s commercial paper. The announcement comes in the wake of Cadbury’s $691 million purchase of the Dr. Pepper Bottling Co. of Texas.
CBRS expects the deal to accrete in 2000, noting that any financing for the purchase will only have a short-term effect on the firm’s credit profile. Cadbury is expecting to realize $US 600 million from the sale of its non-US bottling operations.
The benchmark Canadian stock index was also helped by rising industrial, financial stocks
As vacancies rose, landlords lowered rents on new leases to stay competitive
The result came after a trade deficit of $6.4 billion in August
At the same time, continuing claims are at their lowest level since April
More than 300 new products landed in 2025 — a new record
Canadian cannabis companies surged on reports that Washington will ease federal restrictions on the drug
Never mind the elevated price-to-earnings ratios, a case is being made for a cap-ex powered stock market boom in 2026